These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 12491025

  • 1. Interaction between naltrexone and oral THC in heavy marijuana smokers.
    Haney M, Bisaga A, Foltin RW.
    Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025
    [Abstract] [Full Text] [Related]

  • 2. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.
    Haney M.
    Neuropsychopharmacology; 2007 Jun; 32(6):1391-403. PubMed ID: 17091128
    [Abstract] [Full Text] [Related]

  • 3. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
    Hart CL, Ward AS, Haney M, Comer SD, Foltin RW, Fischman MW.
    Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
    [Abstract] [Full Text] [Related]

  • 4. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.
    Cooper ZD, Haney M.
    Psychopharmacology (Berl); 2010 Aug; 211(2):141-8. PubMed ID: 20490465
    [Abstract] [Full Text] [Related]

  • 5. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
    Curran HV, Brignell C, Fletcher S, Middleton P, Henry J.
    Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
    [Abstract] [Full Text] [Related]

  • 6. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A, Brickner O, Lerman H, Greemland M, Bloch M, Lester H, Chisin R, Sarne Y, Mechoulam R, Bar-Hamburger R, Freedman N, Even-Sapir E.
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [Abstract] [Full Text] [Related]

  • 7. THC-methadone and THC-naltrexone interactions on discrimination, antinociception, and locomotion in rats.
    Wakley AA, Craft RM.
    Behav Pharmacol; 2011 Sep; 22(5-6):489-97. PubMed ID: 21716095
    [Abstract] [Full Text] [Related]

  • 8. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.
    Ramaekers JG, Moeller MR, van Ruitenbeek P, Theunissen EL, Schneider E, Kauert G.
    Drug Alcohol Depend; 2006 Nov 08; 85(2):114-22. PubMed ID: 16723194
    [Abstract] [Full Text] [Related]

  • 9. Factors influencing marijuana self-administration by humans.
    Haney M, Comer SD, Ward AS, Foltin RW, Fischman MW.
    Behav Pharmacol; 1997 Jun 08; 8(2-3):101-12. PubMed ID: 9833006
    [Abstract] [Full Text] [Related]

  • 10. Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.
    Wachtel SR, de Wit H.
    Drug Alcohol Depend; 2000 Jun 01; 59(3):251-60. PubMed ID: 10812285
    [Abstract] [Full Text] [Related]

  • 11. Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.
    Azorlosa JL, Heishman SJ, Stitzer ML, Mahaffey JM.
    J Pharmacol Exp Ther; 1992 Apr 01; 261(1):114-22. PubMed ID: 1313866
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB.
    Exp Clin Psychopharmacol; 2007 Feb 01; 15(1):81-92. PubMed ID: 17295587
    [Abstract] [Full Text] [Related]

  • 14. Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure.
    Hart CL, Haney M, Vosburg SK, Comer SD, Foltin RW.
    Psychopharmacology (Berl); 2005 Sep 01; 181(2):237-43. PubMed ID: 15830233
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.